ENDOXAN N 200MG INJECTION contains Cyclophosphamide, which belongs to a group of medicines called Cytotoxic agents or Anti-cancer agents. It is indicated for malignant diseases in adults and children (such as malignant lymphomas, Hodgkin’s disease, Non-Hodgkin’s lymphoma, lymphocytic lymphoma mixed-cell type lymphoma, histiocytic lymphoma, Burkitt’s lymphoma, multiple myeloma, chronic lymphocytic leukemia, chronic granulocytic leukemia, acute myelogenous and monocytic leukemia, acute lymphoblastic leukemia, mycosis fungoides, neuroblastoma, adenocarcinoma of the ovary, retinoblastoma, Ewing’s sarcoma, breast cancer. It is also used for minimal change nephrotic syndrome in children.
ENDOXAN N 200MG INJECTION is not recommended for use in patients with acute infections, bone-marrow aplasia, urinary tract infections like cystitis, acute urothelial toxicity from cytotoxic chemotherapy or radiation therapy, urinary outflow obstruction, or unmanageed infections. Before receiving ENDOXAN N 200MG INJECTION inform your doctor if you are allergic or have anaphylactic reactions, bone marrow suppression, neutropenic fever, serious infections, severe immune suppression, concomitant chemotherapy and/or radiation therapy, urinary tract and renal diseases, heart diseases, pneumonitis, pulmonary fibrosis, pulmonary veno-occlusive disease, respiratory failure, pneumonitis and secondary malignancies, veno-occlusive liver disease, SIADH (syndrome of inappropriate secretion of antidiuretic hormone), rare hereditary problems of fructose intolerance, galactose intolerance, glucose-galactose malabsorption, Lapp lactase deficiency, sucrase-isomaltase insufficiency, adrenal insufficiency, diabetes and poor general health.
ENDOXAN N 200MG INJECTION is not recommended for use by pregnant women. It is generally not recommended for use in breastfeeding women as it may pass through the breast milk. ENDOXAN N 200MG INJECTION should be used with caution in children and adolescents. It should be...
No content available
